Overall, these results demonstrate that high pS727-STAT3 levels—either in the nucleus or in the cytosol—represent a prognostic factor of low overall survival in advanced-stage ccRCC patients independently of the clinicopathological parameters. The gene discussed is STAT3; the disease is nonpapillary renal cell carcinoma.